Image source, Getty Images By James Gallagher Health and science correspondent The first drug to slow the destruction of the brain in Alzheimer’s has been heralded as momentous. The research breakthrough ends decades of failure and shows a new era of drugs to treat Alzheimer’s – the most common form of dementia – is possible. […]

The post Alzheimer’s Drug Lecanemab Hailed as Momentous Breakthrough, But Not a Cure appeared first on The St Kitts Nevis Observer.